This trial is studying if olaparib and temozolomide may work better in treating patients with small cell lung cancer.
2 Primary · 5 Secondary · Reporting Duration: 2 Years
Experimental Treatment
66 Total Participants · 1 Treatment Group
Primary Treatment: Olaparib · No Placebo Group · Phase 1 & 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: